SERAGON PHARMACEUTICALS INC has a total of 89 patent applications. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), Republic of Korea and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are HUTCHISON MEDIPHARMA ENTPR LTD, ARRAY BIOPHARMA INC and ANVYL LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Republic of Korea | 6 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | Hong Kong | 5 | |
#6 | Israel | 5 | |
#7 | Mexico | 5 | |
#8 | United States | 5 | |
#9 | China | 4 | |
#10 | EAPO (Eurasian Patent Organization) | 4 | |
#11 | WIPO (World Intellectual Property Organization) | 4 | |
#12 | Brazil | 3 | |
#13 | Costa Rica | 3 | |
#14 | Peru | 3 | |
#15 | Philippines | 3 | |
#16 | Singapore | 3 | |
#17 | Taiwan | 3 | |
#18 | Argentina | 2 | |
#19 | Hungary | 2 | |
#20 | Serbia | 2 | |
#21 | Chile | 1 | |
#22 | Colombia | 1 | |
#23 | Japan | 1 | |
#24 | Morocco | 1 | |
#25 | New Zealand | 1 | |
#26 | Ukraine | 1 | |
#27 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Govek Steven P | 74 |
#2 | Kahraman Mehmet | 74 |
#3 | Smith Nicholas D | 74 |
#4 | Nagasawa Johnny Y | 43 |
#5 | Bonnefous Celine | 42 |
#6 | Lai Andiliy G | 36 |
#7 | Julien Jackaline D | 35 |
#8 | Douglas Karensa L | 24 |
#9 | Hager Jeffrey H | 21 |
#10 | Chow Maneval Edna | 19 |
Publication | Filing date | Title |
---|---|---|
EA031077B1 | Estrogen receptor modulator and uses thereof | |
KR20160021281A | Azetidine estrogen receptor modulators and uses thereof | |
US2016355508A1 | Polycyclic estrogen receptor modulators and uses thereof | |
KR20140138296A | Estrogen receptor modulators and uses thereof |